Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Diagnio logo — At-home hormonal and fertility diagnostics empowering women...

Diagnio

At-home hormonal and fertility diagnostics empowering women to achieve the desired family size with less costs & stress

Founded 2022 United Arab Emirates United Arab Emirates 7 employees Pre-Seed Total: $50.00K Health Care, Medical Devices +1

General Information

Company Name Diagnio
Founded Year 2022
Location United Arab Emirates United Arab Emirates
Employees 7
Industries Health Care, Medical Devices, Women's Health
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Diagnio. To contact Diagnio, visit diagnio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diagnio compare?

A PDF of Diagnio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diagnio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diagnio

Diagnio is a UAE-based startup focused on providing at-home hormonal and fertility diagnostics to empower women in managing their family planning with reduced costs and stress. The company's mission is to revolutionize women's health diagnostics by offering lab-accurate, easy-to-use, and continuous at-home experiences. Their first product utilizes saliva samples to measure estrogen levels for determining ovulation and cycle phases through a specialized medical device and mobile application. With a focus on biosensor-generated objective data, personalized analytics algorithms, and online consultations with specialists, Diagnio aims to offer actionable advice to its users. The startup, founded in 2022, is an emerging player in the Health Care industry. Diagnio recently secured a $50.00K Pre Seed Round investment from Expert DOJO on 21 September 2022. With its commitment to R&D, university partnerships, and patent-pending technology for further hormonal panel development, Diagnio presents strong potential for growth and impact in the women's health tech space. Interested parties can pre-order their product with a 20% discount at https://diagnio.com.

Business keywords: women's health, fertility diagnostics, hormonal health, reproductive health, at-home diagnostics, saliva testing, mobile applications, digital health, R&D, biosensors, personalized analytics, online consultations, startup

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $50.00K 1
Expert DOJO
Expert DOJO
21 Sep 2022

Diagnio Alternatives & Competitors

View All Alternatives
Diagnio vs
Parla
Parla United Kingdom

Adia has become Parla ✨ An expert-led community changing the conversation around fertility.

Seed
8 employees
Health Care, Health and Wellness
Diagnio vs
Proov
Proov United States

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful...

Series A
22 employees
Biotechnology, Health Care
Diagnio vs
yesmom
yesmom Singapore

Yesmom makes health information more accessible with at-home blood testing kits and informative digi...

4 employees
Digital Health, Health Care
Also compare with: Diagnio vs Hertility Hertility View all alternatives

FAQ About Diagnio

At-home hormonal and fertility diagnostics empowering women to achieve the desired family size with less costs & stress
Diagnio was founded in 2022.
Diagnio is headquartered in United Arab Emirates.
Diagnio operates in Health Care, Medical Devices and Women's Health. Its work centres on women's health, fertility diagnostics, hormonal health and reproductive health.
Diagnio has approximately 7 employees.
Diagnio has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Diagnio include Parla, Proov, yesmom, The Stork Ib2C, A Rinovum Women's Health Company, Hertility. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diagnio and Parla are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diagnio, https://www.bouncewatch.com/company/diagnio, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout